Correlation of MYCN amplification with MCM7 protein expression in neuroblastomas: A chromogenic in situ hybridization study in paraffin sections

Human Pathology

Volumn 35, Issue 11, 2004, Pages 1397-1403

  Tsai, Hsien Yu ^a   Hsi, Bae Li ^a   Hung, Iou Jih ^a   Yang, Chao Ping ^a   Lin, Jer Nan ^a   Chen, Jeng Chang ^a   Tsai, Shih Feng ^a   Huang, Shiu Feng ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

chromogenic in situ hybridization; CISH; FISH; fluorescence in situ hybridization; MCM protein; MCM7; minichromosome maintenance protein; MYCN; Neuroblastoma

Indexed keywords

ARTICLE; CANCER STAGING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE AMPLIFICATION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFANT; MALE; NEUROBLASTOMA; PROTEIN EXPRESSION;

ADOLESCENT; CELL CYCLE PROTEINS; CHILD; CHILD, PRESCHOOL; DNA-BINDING PROTEINS; FEMALE; GENE AMPLIFICATION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFANT; INFANT, NEWBORN; MALE; NEUROBLASTOMA; NUCLEAR PROTEINS; ONCOGENE PROTEINS; PARAFFIN EMBEDDING; TUMOR MARKERS, BIOLOGICAL;

EID: 10044224285     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2004.07.014     Document Type: Article

References (38)

1. Maris J.M., Matthay K.K. Molecular biology of neuroblastoma. J Clin Oncol. 17:1999;2264-2279
2. Schwab M., Westerman F., Hero B., et al. Neuroblastoma Biology and molecular and chromosomal pathology. Lancet Oncol. 4:2003;472-480
3. Rubie H., Hartmann O., Michon J., et al. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma Results of the French NBL 90 study. Neuroblastoma Study Group of the Societe Francaise d'Oncologie Pediatrique. J Clin Oncol. 15:1997;1171-1182
4. Seeger R.C., Brodeur G.M., Sather H., et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med. 313:1985;1111-1116
5. Brodeur G.M., Seeger R.C., Schwab M., et al. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science. 224:1984;1121-1124
6. Brodeur G.M., Fong C.T. Molecular biology and genetics of human neuroblastoma. Cancer Genet Cytogenet. 41:1989;53-74
7. Tonini G.P., Boni L., Pession A., et al. MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s The Italian experience with 295 children. J Clin Oncol. 15:1997;85-93
8. Castle V.P., Heidelberger K.P., Bromberg J., et al. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification. Am J Pathol. 143:1993;1543-1550
9. Cohn S.L., London W.B., Huang D., et al. MYCN expression is not prognostic of adverse outcome in advanced-stage neuroblastoma with nonamplified MYCN. J Clin Oncol. 18:2000;3604-3613
10. George R.E., Kenyon R., McGuckin A.G., et al. Analysis of candidate gene co-amplification with MYCN in neuroblastoma. Eur J Cancer. 33:1997;2037-2042
11. Nesbit C.E., Tersak J.M., Prochownik E.V. MYC oncogenes and human neoplastic disease. Oncogene. 18:1999;3004-3016
12. Shohet J.M., Hicks M.J., Plon S.E., et al. Minichromosome maintenance protein MCM7 is a direct target of the MYCN transcription factor in neuroblastoma. Cancer Res. 62:2002;1123-1128
13. Spellman P.T., Sherlock G., Zhang M.Q., et al. Comprehensive identification of cell cycle-regulated genes of the yeast Saccharomyces cerevisiae by microarray hybridization. Mol Biol Cell. 12:1998;3273-3297
14. Kearsey S.E., Labib K. MCM proteins Evolution, properties, and role in DNA replication. Biochim Biophys Acta. 1398:1998;113-136
15. Lei M., Tye B.K. Initiating DNA synthesis From recruiting to activating the MCM complex. J Cell Sci. 114:2001;1447-1454
16. Maiorano D., Lemaitre J.M., Mechali M. Stepwise regulated chromatin assembly of MCM2-7 proteins. J Biol Chem. 275:2000;8426-8431
17. Ritzi M., Knippers R. Initiation of genome replication Assembly and disassembly of replication-competent chromatin. Gene. 245:2000;13-20
18. Schaarschmidt D., Ladenburger E.M., Keller C., et al. Human Mcm proteins at a replication origin during the G1 to S phase transition. Nucleic Acids Res. 30:2002;4176-4185
19. Williams G.H., Romanowski P., Morris L.S., et al. Improved cervical smear assessment antibodies against proteins that regulate DNA replication. Proc Natl Acad Sci U S A. 95:1998;14932-14937
20. Freeman A., Morris L.S., Mills A.D., et al. Minichromosome maintenance proteins as biological markers of dysplasia and malignancy. Clin Cancer Res. 5:1999;2121-2132
21. Todorov I.T., Werness B.A., Wang H.Q., et al. HsMCM2/BM28 A novel proliferation marker for human tumors and normal tissues. Lab Invest. 78:1998;73-78
22. Brake T., Connor J.P., Petereit D.G., et al. Comparative analysis of cervical cancer in women and in a human papillomavirus-transgenic mouse model Identification of minichromosome maintenance protein 7 as an informative biomarker for human cervical cancer. Cancer Res. 63:2003;8173-8180
23. Hiraiwa A., Fujita M., Adachi A., et al. Specific distribution patterns of hCDC47 expression in cutaneous diseases. J Cutan Pathol. 25:1998;285-290
24. Cromer A., Carles A., Millon R., et al. Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis. Oncogene. 23:2004;2484-2498
25. Shapiro D.N., Valentine M.B., Rowe S.T., et al. Detection of N-myc gene amplification by fluorescence in situ hybridization. Diagnostic utility for neuroblastoma. Am J Pathol. 142:1993;1339-1346
26. Tajiri T., Shono K., Fujii Y., et al. Highly sensitive analysis for N-myc amplification in neuroblastoma based on fluorescence in situ hybridization. J Pediatr Surg. 34:1999;1615-1619
27. Taylor C.P., McGuckin A.G., Bown N.P., et al. Rapid detection of prognostic genetic factors in neuroblastoma using fluorescence in situ hybridisation on tumour imprints and bone marrow smears. Br J Cancer. 69:1994;445-451
28. De Bernardi B., Conte M., Mancini A., et al. Localized resectable neuroblastoma Results of the second study of the Italian Cooperative Group for Neuroblastoma. J Clin Oncol. 13:1995;884-893
29. Schmidt M.L., Lukens J.N., Seeger R.C., et al. Biologic factors determine prognosis in infants with stage IV neuroblastoma A prospective Children's Cancer Group study. J Clin Oncol. 18:2000;1260-1268
30. Huang S.F., Hudson T.J., Renshaw A.A., et al. Fluorescence in situ hybridization evaluation of chromosome deletion patterns in prostate cancer. Am J Pathol. 149:1996;1565-1573
31. Huang S.F., Hsu H.C., Fletcher J.A. Investigation of chromosomal aberrations on hepatocellular carcinoma by fluorescence in situ hybridization. Cancer Genet Cytogenet. 111:1999;21-27
32. Huang S.F., Hsu H.C., Chen J.C., et al. Tetrasomy 6 and 6q14 deletion are associated with better survival in hepatocellular carcinomas - A fluorescence in situ hybridization study of 77 cases. Cancer Genet Cytogenet. 144:2003;23-30
33. Tanner M., Gancberg D., Di Leo A., et al. Chromogenic in situ hybridization A practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples. Am J Pathol. 157:2000;1467-1472
34. Dandachi N., Dietze O., Hauser-Kronberger C. Chromogenic in situ hybridization A novel approach to a practical and sensitive method for the detection of HER2 oncogene in archival human breast carcinoma. Lab Invest. 82:2002;1007-1014
35. Zhao J., Wu R., Au A., et al. Determination of HER2 gene amplification by chromogenic in situ hybridization (CISH) in archival breast carcinoma. Mod Pathol. 15:2002;657-665
36. Gupta D., Middleton L.P., Whitaker M.J., et al. Comparison of fluorescence and chromogenic in situ hybridization for detection of HER-2/neu oncogene in breast cancer. Am J Clin Pathol. 119:2003;381-387
37. Vera-Roman J.M., Rubio-Martinez L.A. Comparative assays for the HER-2/neu oncogene status in breast cancer. Arch Pathol Lab Med. 128:2004;627-633
38. Marquez A., Wu R., Zhao J., et al. Evaluation of epidermal growth factor receptor (EGFR) by chromogenic in situ hybridization (CISH) and immunohistochemistry (IHC) in archival gliomas using bright-field microscopy. Diagn Mol Pathol. 13:2004;1-8